Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Yi Chang Zhao"'
Autor:
Yi-Chang Zhao, Zhi-Hua Sun, Jia-Kai Li, Huai-yuan Liu, Hua-Lin Cai, Wei Cao, Feng Yu, Bi-Kui Zhang, Miao Yan
Publikováno v:
Environmental Sciences Europe, Vol 36, Iss 1, Pp 1-8 (2024)
Abstract Background Bacterial drug resistance represents a significant global concern, with vancomycin-resistant Enterococcus faecalis posing a particularly grave threat to contemporary healthcare systems. This study aims to reveal the reasons for th
Externí odkaz:
https://doaj.org/article/d99fc7cfac4b40a0bae36dbd42c1cb6a
Autor:
Yi-Chang Zhao, Zhi-Hua Sun, Jia-Kai Li, Huai-Yuan Liu, Bi-Kui Zhang, Xu-Biao Xie, Chun-Hua Fang, Indy Sandaradura, Feng-Hua Peng, Miao Yan
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
ObjectivesSignificant increase in tacrolimus exposure was observed during co-administration with voriconazole, and no population pharmacokinetic model exists for tacrolimus in renal transplant recipients receiving voriconazole. To achieve target tacr
Externí odkaz:
https://doaj.org/article/34320ba5c9834710bdc9cd0752a7381c
Autor:
Shuang Xia, Hui Gong, Yi-kun Wang, Ling Liu, Yi-chang Zhao, Lin Guo, Bi-kui Zhang, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Pneumocystis jirovecii pneumonia (PJP) has been reported with ICIs but limited to case reports. The clinical features of PJP with ICIs remain mostly unknown. This study aims to investigate the association of PJP with ICIs and describe cli
Externí odkaz:
https://doaj.org/article/974f5509f12b4491b9420bfd0fb01982
Autor:
Shuang Xia, Yi-Chang Zhao, Lin Guo, Hui Gong, Yi-Kun Wang, Rui Ma, Bi-Kui Zhang, Yue Sheng, Mayur Sarangdhar, Yoshihiro Noguchi, Miao Yan
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Introduction: Antibody–drug conjugates (ADCs) produce unparalleled efficacy in refractory neoplasms but can also lead to serious toxicities. Although ADC-related sepsis has been reported, the clinical features are not well characterized in real-wor
Externí odkaz:
https://doaj.org/article/9b7ffb60bb1e46d18313c983be054721
Autor:
Yi‐Chang Zhao, Xiao‐Bin Lin, Bi‐Kui Zhang, Yi‐wen Xiao, Ping Xu, Feng Wang, Da‐Xiong Xiang, Xu‐Biao Xie, Feng‐Hua Peng, Miao Yan
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 2, Pp 702-711 (2021)
Voriconazole is the mainstay for the treatment of invasive fungal infections in patients who underwent a kidney transplant. Variant CYP2C19 alleles, hepatic function, and concomitant medications are directly involved in the metabolism of voriconazole
Externí odkaz:
https://doaj.org/article/a7d067fcc5ae48b3b82b61514aa16f8a
Autor:
Yi-Chang Zhao, Chen-Lin Xiao, Jing-Jing Hou, Jia-Kai Li, Bi-Kui Zhang, Xu-Biao Xie, Chun-Hua Fang, Feng-Hua Peng, Indy Sandaradura, Miao Yan
Publikováno v:
Pharmaceutics, Vol 14, Iss 12, p 2739 (2022)
Tacrolimus is an immunosuppressant with a narrow therapeutic window. Tacrolimus exposure increased significantly during voriconazole co-therapy. The magnitude of this interaction is highly variable, but it is hard to predict quantitatively. We conduc
Externí odkaz:
https://doaj.org/article/1d22d72bd18f4bda986a7859af7cdd04
Autor:
Yi-Chang Zhao, Yang Zou, Jing-Jing Hou, Chen-Lin Xiao, Bi-Kui Zhang, Jia-Kai Li, Da-Xiong Xiang, Indy Sandaradura, Miao Yan
Publikováno v:
Antibiotics, Vol 10, Iss 12, p 1542 (2021)
Voriconazole is a triazole antifungal agent commonly used for the treatment and prevention of invasive aspergillosis (IA). However, the study of voriconazole's use in children is limited. The present study was performed to explore maintenance dose to
Externí odkaz:
https://doaj.org/article/98db93defec24fb188efbda69ef76f9c
Autor:
Xubiao Xie, Ping Xu, Bikui Zhang, Feng Wang, Fenghua Peng, Xiao-bin Lin, Da-Xiong Xiang, Yi-Wen Xiao, Miao Yan, Yi-Chang Zhao
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 2, Pp 702-711 (2021)
Clinical and Translational Science, Vol 14, Iss 2, Pp 702-711 (2021)
Voriconazole is the mainstay for the treatment of invasive fungal infections in patients who underwent a kidney transplant. Variant CYP2C19 alleles, hepatic function, and concomitant medications are directly involved in the metabolism of voriconazole
Autor:
Bikui Zhang, Xi‐jing Chen, Feng Wang, Yi Tian, Guozhong Gong, Min Zhang, Yongfang Jiang, Jianjun Zou, Yi-Wen Xiao, Miao Yan, Da-Xiong Xiang, Yi-Chang Zhao, Wenlong Wang, Wu Liang, Bai‐li Song, Dan Tang
Publikováno v:
British Journal of Clinical Pharmacology. 87:1890-1902
AIMS Voriconazole is a broad-spectrum antifungal agent for the treatment of invasive fungal infections. There is limited information about the pharmacokinetics and appropriate dosage of voriconazole in patients with liver dysfunction. This study aime
Autor:
Feng Wang, Min Zhang, Yongfang Jiang, Bikui Zhang, Jiakai Li, Guozhong Gong, Da-Xiong Xiang, Yi-Wen Xiao, Miao Yan, Yi-Chang Zhao, Jingjing Hou
Publikováno v:
Antibiotics, Vol 10, Iss 1130, p 1130 (2021)
Antibiotics
Volume 10
Issue 9
Antibiotics
Volume 10
Issue 9
This prospective observational study aimed to clinically describe voriconazole administrations and trough concentrations in patients with Child–Pugh class C and to investigate the variability of trough concentration. A total of 144 voriconazole tro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d16f153d716059d45425e5220d77d5b